The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Science Is On The Trail Of Sexual Predators That Dope Women

RAPISTS who drug their victims so that they don't remember what happened to them could soon be easier to catch, thanks to a test developed by scientists in Ireland. The simple urine test can detect the "date rape drug" Rohypnol up to a week after it has been taken.

Rohypnol is a powerful sedative used to treat insomnia. It has never been approved for use in the US, but is available in Europe on prescription. High doses can cause amnesia for up to 24 hours.

The tablets, known as "roofies", have no taste or smell when dissolved in water. Worldwide, thousands of women believe they have been raped after someone slipped Rohypnol into their drink. Hoffmann-La Roche, which makes the drug, has reformulated its tablets so that they turn drinks blue, but illicit tablets are still available on the black market.

Rohypnol belongs to a class of sedatives called benzodiazepines, which includes Valium. But it is 10 times as potent as other drugs in the class, and so is used in much smaller quantities, making it very difficult to detect. Existing antibody tests, developed for other benzodiazepines, often miss Rohypnol.

Kieran Walshe and his colleagues at University College Dublin have developed a more sensitive test. Working with a team at Trinity College, also in Dublin, they obtained antibodies to the major metabolite of Rohypnol, 7-aminoflunitrazepam. They also bound the metabolite to an enzyme that catalyses a reaction that causes a colour change.

For the test, the antibodies are fixed to a solid support and exposed to a urine sample mixed with the enzyme-linked 7-aminoflunitrazepam. Any metabolite present in the urine competes with the enzyme-metabolite complex, preventing it binding to the antibodies. The more metabolite there is in the sample, the less enzyme binds to the antibodies, and the weaker the colour produced. "We also pick up other metabolites and unmetabolised Rohypnol," says Walshe.

The
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-171-331-2751
New Scientist
9-Dec-1998


Page: 1 2

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. 2005 Behavioral Sciences & Health Services Research Award
3. Innovation prize finalists announced in Science of Better
4. NIH panel issues State-of-the-Science statement on end-of-life care
5. 2004 Science-in-Society Award winners announced
6. Dec. 10-12 Japanese-American Frontiers of Science Meeting in Irvine, Calif.
7. GSA bestows Robert W. Kleemeier Award to University of Texas Health Science Centers Smith
8. Scripps atmospheric scientist appointed to Pontifical Academy of Sciences
9. Science of better convenes operations researchers in Denver
10. National Academies advisory: Nov. 4-6 Frontiers of Science meeting in Irvine, Calif.
11. Research news from the Friedman School of Nutrition Science and Policy at Tufts University

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Science The Trail Sexual Predators That Dope Women

(Date:11/23/2009)...rgetIndividualsintheRecommendedPriorityGroups ,...TheDepartmentofHealthannouncedtodaytheywillconduct...ealthCentersinDelaware,Lancaster,andLehighcounties...ewillbeadministeredforfreetoindividualsintherecomm...vaccine.Thedepartmentasksthatonlyindividualsinthef...
(Date:11/23/2009)... compounds appears to cause oxidative DNA damage a... a new study published online November 23 in the ...hough biomethylation was once believed to detoxify...ts toxicity and potentially its carcinogenicity. ...in oxidative DNA damage in mice, Michael P. Waalke...
(Date:11/23/2009)...e children who don,t access health care from the s...ficantly more likely to have unmet health care nee...y published in the journal Pediatrics . , Stud...ng and delivery of quality health care for childre...licy debates about health insurance reform, much o...
(Date:11/23/2009)...-- A first-of-its-kind consensus statement on diab...als of Surgery . The report illustrates the findin... -- Diabetes Surgery Summit (DSS) -- where an inte...ical experts agreed on a set of evidence-based gui...e use and study of gastrointestinal surgery to tre...
(Date:11/23/2009)...tting chemo deal with insomnia, study shows , ...ia and sleep disorders affect more than three-quar... rate nearly three times higher than that of the g...blem is more common in younger patients and in tho...f Rochester Medical Center researchers, who assess...
Breaking Medicine News(10 mins):Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5
(Date:11/23/2009)...nker.comannouncesthatanewmarketresearchreportisava...ables-AWorldwideMarketReview ,, http://www.r...les---A-Worldwide-Market-Review.html#utm_source=pr...wire ,, Withincreaseinrangeofinfectiousdise...italfacilities,nonwovenshasemergedasagoldmineforro...
(Date:11/23/2009)...ightSciencesOncology,Inc.(LSO)todayannouncedtheele...ewlycreatedseatonitsboardofdirectors.Mr.Seddighisw...es,includingElekta,tomarketleadership. ,, "Thea...businessdevelopmenttotheboard,"saidLSO,sChairmanof...cer-therapybusinessdevelopment.Hehasoverseentheeme...
(Date:11/23/2009)...ndsResearchGroup,Inc.releasedWave2ofits LaunchTre...sesyndicatedmarketresearchprojecttrackingthelaunch...ixmonthsofproductavailability.Eachwaveofthereportp...gistsandqualitativeinformationfromasubsetof15.Ther...easonstouse,typicalpatienttypes,productperceptions...
Breaking Medicine Technology:Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 2Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 4Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 5Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 6Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 8Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Orexigen 28R 29 Therapeutics Announces In Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave 28R 29 48582 1Orexigen 28R 29 Therapeutics Announces In Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave 28R 29 48582 2Orexigen 28R 29 Therapeutics Announces In Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave 28R 29 48582 3Moving Beyond the Mysteries of Disruption Reporting 48579 1Moving Beyond the Mysteries of Disruption Reporting 48579 2PharmaSURVEYORs Advanced Drug Safety Service Connects to Microsoft HealthVault 48576 1PharmaSURVEYORs Advanced Drug Safety Service Connects to Microsoft HealthVault 48576 2
Other News:
Roche announced that the European Commission has granted marketing authorisation for Roches anti-cancer tablet Xeloda (capecitabine) for the treatment of metastatic breast cancer. The Commission grant
...e University researchers have calculated that brie...age teen drinking are both beneficial and cost-eff...n intervention programs for adolescents was return... costs associated with alcohol problems in adultho...
...ES, CA (May 1, 2002) Researchers at Cedars-Sinai ...d pill improves the overall survival of patients w... in bone marrow. The study, published in the May ...ts who received oral prednisone over the long term...
...New Jersey (May 2, 2002) - Data presented for the ... Ophthalmology in Sydney, Australia, show that lon...reg; (latanoprost ophthalmic solution) presented n...a-ocular pressure (IOP) in patients with open-angl...
health news:Xeloda approved for breast cancer treatment in Europe 2health news:Xeloda approved for breast cancer treatment in Europe 3health news:Study quantifies cost-benefit of family interventions to prevent teen alcohol use 2health news:Steroid pill prolongs survival in patients with multiple myeloma 2health news:Steroid pill prolongs survival in patients with multiple myeloma 3health news:Long-term safety data on Xalatan presented 2
New York, NY (May 17, 2005) The New York University Child Study Center is pleased to announce the Third Annual Adam Katz Lecture Series, which includes two lectures on Thursday, May 19 and Friday, Ma
...eract with their children early in infancy might l... A small pilot study published this month in Nutri...dren more energy- rich food, and spent less time f...t women.......Infancy may be one of the critical p...
* Press Conference 1, Friday, 3 June 2005, 13:00-14:00...Breast cancer, Colorectal cancer, Supportive Care, Health Services and Public Health...* Press Conference 2, Saturday, 4 June 2005, 8:30-9:30..
LAUREL, MD-The American Institute of Ultrasound in Medicine (AIUM) will present Richard A. Meyer, MD, with the 2005 William J. Fry Award for his numerous contributions to the scientific progress of di
health news:NYU Child Study Center presents third Annual Adam Katz Memorial Lecture series 2health news:Over-feeding in infancy might set the stage for childhood obesity 2health news:Richard A. Meyer, MD, receives the 2005 AIUM William J. Fry Memorial Lecture Award 2